These findings, supported by the pseudotemporal trajectory analysis, suggested a continuum of CD8+ cells with an intermediary, distinctive, CD8+ GZMK population in AML that is characterized by high GZMK expression, and harbored stem-like and memory T cell markers. The gene discussed is GZMK; the disease is acute myeloid leukemia.